Filing Details

Accession Number:
0000950170-24-029324
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-11 16:30:18
Reporting Period:
2024-03-07
Accepted Time:
2024-03-11 16:30:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1801395 Paul Blanchfield C/O Lantheus Holdings, Inc.
201 Burlington Road, South Building
Bedford MA 01730
President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-07 18,023 $61.96 103,357 No 4 S Direct
Common Stock Disposition 2024-03-07 500 $0.00 102,857 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2023.